Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NATR
|
Terrence Moorehead
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,319 Added 3.64% |
-
|
Oct 14
2020 |
|
NATR
|
Joseph W Baty
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,041 Reduced 1.02% |
$12,534
$12.04 p/Share
|
Oct 14
2020 |
|
NATR
|
Joseph W Baty
EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,259 Added 4.02% |
-
|
Oct 14
2020 |
|
KRON
|
Norbert W Bischofberger |
BUY
Open market or private purchase
|
Indirect | 95,500 Added 2.14% |
$1,814,500
$19.0 p/Share
|
Oct 14
2020 |
|
KRON
|
Norbert W Bischofberger |
BUY
Conversion of derivative security
|
Indirect | 3,208,835 Added 34.92% |
$51,822,684
$16.15 p/Share
|
Oct 14
2020 |
|
KRON
|
Bischofberger Norbert W. & Inger A. Revocable Inter Vivos Trust
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 95,500 Added 2.14% |
$1,814,500
$19.0 p/Share
|
Oct 14
2020 |
|
KRON
|
Bischofberger Norbert W. & Inger A. Revocable Inter Vivos Trust
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 2,153,835 Added 33.5% |
$34,784,434
$16.15 p/Share
|
Oct 14
2020 |
|
KRON
|
Yasir B. Al Wakeel
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 5,250 Added 12.36% |
$99,750
$19.0 p/Share
|
Oct 14
2020 |
|
KRON
|
Christopher Dinsmore
Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct | 5,250 Added 50.0% |
$99,750
$19.0 p/Share
|
Oct 14
2020 |
|
KRON
|
Barbara Kosacz
COO & General Counsel |
BUY
Open market or private purchase
|
Direct | 5,250 Added 0.85% |
$99,750
$19.0 p/Share
|
Oct 14
2020 |
|
KRON
|
Arie Belldegrun |
BUY
Conversion of derivative security
|
Indirect | 2,739,052 Added 31.1% |
$44,235,689
$16.15 p/Share
|
Oct 14
2020 |
|
KRON
|
Rebecka Belldegrun
Director |
BUY
Conversion of derivative security
|
Indirect | 423,738 Added 27.79% |
-
|
Oct 14
2020 |
|
KRON
|
Joshua A Kazam |
BUY
Conversion of derivative security
|
Direct | 92,371 Added 49.44% |
-
|
Oct 14
2020 |
|
KRON
|
Jakob Loven
Director |
BUY
Conversion of derivative security
|
Indirect | 1,545,344 Added 29.93% |
$24,957,305
$16.15 p/Share
|
Oct 14
2020 |
|
KRON
|
John C Martin
Director |
BUY
Open market or private purchase
|
Indirect | 75,800 Added 3.74% |
$1,440,200
$19.0 p/Share
|
Oct 14
2020 |
|
KRON
|
John C Martin
Director |
BUY
Conversion of derivative security
|
Indirect | 1,876,564 Added 30.34% |
$30,306,508
$16.15 p/Share
|
Oct 14
2020 |
|
KRON
|
Elena Ridloff |
BUY
Open market or private purchase
|
Direct | 2,630 Added 50.0% |
$49,970
$19.0 p/Share
|
Oct 14
2020 |
|
KRON
|
David M Tanen |
BUY
Conversion of derivative security
|
Indirect | 339,355 Added 19.99% |
$5,480,583
$16.15 p/Share
|
Oct 14
2020 |
|
KRON
|
David M Tanen |
BUY
Conversion of derivative security
|
Direct | 231,553 Added 38.92% |
-
|
Oct 14
2020 |
|
KRON
|
Otello Stampacchia
Director |
BUY
Open market or private purchase
|
Indirect | 450,000 Added 10.54% |
$8,550,000
$19.0 p/Share
|
Oct 14
2020 |
|
KRON
|
Otello Stampacchia
Director |
BUY
Conversion of derivative security
|
Indirect | 3,348,832 Added 30.31% |
$54,083,636
$16.15 p/Share
|
Oct 14
2020 |
|
KRON
|
Omega Fund V, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 450,000 Added 10.54% |
$8,550,000
$19.0 p/Share
|
Oct 14
2020 |
|
KRON
|
Omega Fund V, L.P.
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 3,348,832 Added 49.86% |
$54,083,636
$16.15 p/Share
|
Oct 14
2020 |
|
ALTO
|
Neil M Koehler
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 55,155 Reduced 5.98% |
$526,730
$9.55 p/Share
|
Oct 14
2020 |
|
APEI
|
Barbara Fast
Director |
SELL
Open market or private sale
|
Direct | 250 Reduced 1.2% |
$7,735
$30.94 p/Share
|
Oct 14
2020 |
|
GRPN
|
Ann Elizabeth Ziegler
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,595 Added 25.34% |
-
|
Oct 14
2020 |
|
ZUMZ
|
Adam Christopher Ellis
President International |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 14.15% |
$160,000
$32.0 p/Share
|
Oct 14
2020 |
|
CHRS
|
Jean Frederic Viret
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 6,144 Reduced 13.19% |
$116,736
$19.0 p/Share
|
Oct 14
2020 |
|
FLWS
|
Christopher G Mccann
Director |
SELL
Open market or private sale
|
Direct | 27,725 Reduced 2.46% |
$794,321
$28.65 p/Share
|
Oct 14
2020 |
|
FLWS
|
Christopher G Mccann
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 27,725 Added 2.4% |
$49,628
$1.79 p/Share
|
Oct 14
2020 |
|
CRAI
|
Jonathan D Yellin
EVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct | 3,243 Reduced 21.14% |
$126,704
$39.07 p/Share
|
Oct 14
2020 |
|
CRAI
|
Jonathan D Yellin
EVP AND GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct | 3,243 Added 17.45% |
$59,931
$18.48 p/Share
|
Oct 14
2020 |
|
HCAT
|
Timothy G. Ferris |
SELL
Open market or private sale
|
Direct | 2,333 Reduced 30.0% |
$82,238
$35.25 p/Share
|
Oct 14
2020 |
|
HCAT
|
Timothy G. Ferris |
BUY
Exercise of conversion of derivative security
|
Direct | 2,333 Added 23.08% |
$27,483
$11.78 p/Share
|
Oct 14
2020 |
|
REPL
|
Pamela Esposito
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 16,000 Reduced 12.43% |
$521,600
$32.6 p/Share
|
Oct 14
2020 |
|
REPL
|
Pamela Esposito
Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 16,000 Added 11.06% |
$16,160
$1.01 p/Share
|
Oct 14
2020 |
|
QURE
|
Matthew C Kapusta
CEO, Managing Director |
SELL
Open market or private sale
|
Direct | 5,250 Reduced 1.84% |
$189,840
$36.16 p/Share
|
Oct 14
2020 |
|
ADPT
|
Michelle Renee Griffin
Director |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 100.0% |
$633,360
$52.78 p/Share
|
Oct 14
2020 |
|
ADPT
|
Michelle Renee Griffin
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 12,000 Added 50.0% |
$93,600
$7.8 p/Share
|
Oct 14
2020 |
|
ADPT
|
Michael J Pellini
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 100.0% |
$2,621,000
$52.42 p/Share
|
Oct 14
2020 |
|
ADPT
|
Michael J Pellini
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 50,000 Added 50.0% |
$327,500
$6.55 p/Share
|
Oct 14
2020 |
|
ADPT
|
Harlan S Robins
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 11,100 Reduced 94.24% |
$581,196
$52.36 p/Share
|
Oct 14
2020 |
|
ADPT
|
Harlan S Robins
Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 11,100 Added 48.52% |
$70,152
$6.32 p/Share
|
Oct 14
2020 |
|
SILK
|
Lucas W. Buchanan
COO & CFO |
SELL
Open market or private sale
|
Direct | 9,600 Reduced 7.96% |
$626,016
$65.21 p/Share
|
Oct 14
2020 |
|
SILK
|
Lucas W. Buchanan
COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 9,600 Added 7.53% |
$45,408
$4.73 p/Share
|
Oct 14
2020 |
|
TLRY
|
Brendan Kennedy
Director |
SELL
Open market or private sale
|
Direct | 400,000 Reduced 3.37% |
$2,332,000
$5.83 p/Share
|
Oct 14
2020 |
|
MDRX
|
Lisa Khorey
Chief Client Delivery Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 5.25% |
$165,600
$11.04 p/Share
|
Oct 14
2020 |
|
MDRX
|
Paul Black
Director |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 1.73% |
$331,200
$11.04 p/Share
|
Oct 14
2020 |
|
PCRX
|
David M Stack
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 14.75% |
$1,665,900
$55.53 p/Share
|
Oct 14
2020 |
|
PCRX
|
David M Stack
CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 30,000 Added 12.85% |
$324,300
$10.81 p/Share
|
Oct 14
2020 |